Journal article
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
Abstract
BACKGROUND: Previous trials have shown that the use of statins to lower cholesterol reduces the risk of cardiovascular events among persons without cardiovascular disease. Those trials have involved persons with elevated lipid levels or inflammatory markers and involved mainly white persons. It is unclear whether the benefits of statins can be extended to an intermediate-risk, ethnically diverse population without cardiovascular disease.
Authors
Yusuf S; Bosch J; Dagenais G; Zhu J; Xavier D; Liu L; Pais P; López-Jaramillo P; Leiter LA; Dans A
Journal
The New England Journal of Medicine, Vol. 374, No. 21, pp. 2021–2031
Publisher
Massachusetts Medical Society
Publication Date
May 26, 2016
DOI
10.1056/nejmoa1600176
ISSN
0028-4793